Changes in bone mineral density after adjuvant aromatase inhibitors and fracture risk in breast cancer patients
- PMID: 17416873
- DOI: 10.1200/JCO.2006.08.7080
Changes in bone mineral density after adjuvant aromatase inhibitors and fracture risk in breast cancer patients
Comment on
-
Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17.J Clin Oncol. 2006 Aug 1;24(22):3629-35. doi: 10.1200/JCO.2005.05.4882. Epub 2006 Jul 5. J Clin Oncol. 2006. PMID: 16822845 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
